PET Scan Can Non-Invasively Measure Early Assessment Of Treatment For Common Type Of Breast Cancer

Non-invasive imaging can measure how well patients with the most common form of breast cancer — estrogen receptor positive type — respond to standard aromatase inhibitor therapy after only two weeks and shows similar findings that more invasive needle sampling identifies, according to new research.